the progressive late onset bronchiectasis (Squire 1962) , autoantibodies and allergic manifestations still occur (Wollheim et al. 1964) . The patient has suffered from repeated transfusion reactions due to strong cytotoxic antibodies to leukocytes. It is therefore of interest that both lichen planus and alopecia areata have developed in this context, and have both been particularly aggressive.
The skin histopathology shows numerous colloid-hyaline-Civatte-like bodies in the dermoepidermal region, and there is a definite tendency for grouping (Fig 2A) . Similar discrete eosinophilic structures are present throughout all layers of the epidermis, even the stratum corneum ( Fig  2B) . Some of these may be related to sweat ducts and could be due to inspissated secretions. Those in the prickle cell layer are not, however; surrounded by a ductal arrangement of cells (Fig 2c) . The bodies were predominantly PAS negative, and were quite separate from the stained sweat ducts. Direct immunofluorescent techniques on cryostat sections failed to show deposits of immunoglobulins or complement on these structures. These findings differ from those of Ueki (1969) .
It seems that, whatever their nature, the bodies are being extruded unchanged on to the skin surface. These unusual features may be related to the fact that, in this patient, lichen planus has developed on a background of impaired immune reactivity. The grouping of these structures, their extrusion unchanged, and their presence in large numbers in a patient with immune deficiency may provide further evidence for their viral nature (Thyresson & Moberger 1957 Arthritis & Rheumatism, 9,464 (1971) In: Immunobiology. Ed Dr P D Samman: I have seen one other patient with myasthenia gravis who also has lichen planus. He started with lichen planus some six years ago then developed myasthenia gravis and is now losing most of his nails as a resulPof the lichen planus.
Dr C M Ridley: Dr Arnold Bloom has under his care at the Whittington Hospital a woman born in 1901 whose mother and maternal grandmother had diabetes. Vitiligo developed in 1929 and she went grey in about 1941. Diabetes mellitus was diagnosed in 1965, idiopathic Addison's disease in 1966 and pernicious anmmia also in 1966. Antibodies to adrenal and parietal cells present (antinuclear factor negative, no antibodies to thyroid, smooth muscle or mitochondria). In 1965 she was seen by Dr P J Hare and was found to have widespread lichen planus. This involved the scalp with complete hair loss. The lichen planus cleared in a few months but the hair has not regrown. The scalp now shows some atrophy and scarring. She did not develop alopecia aroata. This patient was reported by Turner & Bloom (1968 Postgraduate Medical Journal 44, 555-558 LG, woman aged 62 History: Recurrent painful eruptions at the same sites on the dorsum of both hands for 21 years.
The eruption was initially bullous and recently erythematous and associated with cedema of the hands. Macular areas of hyperpigmentation persist between attacks (Fig 1) . The mouth was occasionally affected. She has repeatedly and emphatically denied taking any drugs or medicines, and has been challenged on two separate occasions whilst still in hospital with eighteen different drugs including sulphadimidine, all of which failed to induce an attack. Due to the distressing symptoms she was given two separate courses of prednisone (for 8 months and 4 weeks) but with no benefit. Eventually, after 21 years she admitted to taking Cremostrep (succinyl sulphathiazole 500 mg/5 ml, streptomycin 50 mg/5 ml) for her bowels, but was adamant that this product was not associated with the attacks. In the last few months she has developed a clothing dermatitis. challenge, chiefly due to neutrophils, but also lymphocytes, eosinophils and pigment laden macrophages. The appearances are similar to erythema multiforme and fully consistent with a fixed drug eruption.
Comment
This patient demonstrates the difficulty frequently encountered of incriminating a drug for a clinically obvious fixed drug eruption. Although each attack was associated with such severe pain that she dreaded the possibility offurther episodes, it took almost 21 years of repeated interrogations before the offending product was finally discovered. The cause of her troubles had probably been in her medicine cupboard all this time and an early visit to the patient's home would have relieved her ofmuch suffering.
Although she reacted to 5 ml Cremostrep, testing with streptomycin alone was negative. Therefore, the poorly absorbed sulphonamide succinyl sulphathiazole was incriminated. It was found she also reacted to the related drug phthalyl sulpathiazole. This is not surprising as these two drugs are hydrolysed in the gut to sulphathiazole ( 2), 5% of which is absorbed (Weinstein 1970) .
Further challenges showed that she was not sensitive to the sulphonamido group (b, in Fig 3) . This would account for the negative reaction to the sulphadimidine challenge 24 years previously.
The sensitivity is directed against the thiazole ring (c in Fig 3) and seems to be highly specific, as she did not react to sulphamethiazole or thiabendazole, both of which have similar thiazole rings (Fig 3) . Upon rechallenge, fourteen days after a previous, positive reaction, the eruption appeared only after 24 hours instead of 45 minutes, and was less severe. This would support the existence of at least a partial refractory period (Browne 1964 , Porter & Comaish 1969 . During the positive oral challenge there was no reactivation at the sites of clothing dermatitis. These two sensitivities are not related in this patient, as it is the thiazole ring to which she is sensitive, not the sulphonamido group. Thus there should be no reason for cross-sensitization with an azo dye.
Patch testing with the offending drug over the site of the fixed drug eruption was negative. This procedure in the past has produced conflicting results and is not a sufficiently reliable'method for finding the offending drug. It may well be that a more efficient vehicle is needed or a higher concentration of the drug. Porter & Comaish (1969) for their positive reaction used a 30 % solution of sulphadimidine.
In view of the often unhelpful history in these cases (she still does not believe that her bowel medicine was the cause of her distressing symptoms), oral challenge with a battery of commonly 12 incriminated drugs and perhaps also an early visit to the patient's home would be advisable. One of the 'non-absorbable' sulphonamides should be added to such a test battery.
Dr D E Sharvill: Dr Tan's beautiful presentation underlines the difficulty in diagnosing such eruptions. An intelligent executive recently under my care had three typical attacks and insisted that each followed a visit to the dentist. On careful checking no real relationship could be established. He had the following drugs in his possession, taking some regularly, some occasionally: co-trimoxazole, oxytetracycline, quinidine, propranolol, succinyl sulphathiazole, nitrazepam and butobarbitone.
These drugs were powdered in numbered packets, alternating with lactose, and the patient was told to take a powder nightly. The morning after taking the succinyl sulphathiazole he woke up with a typical fixed drug eruption involving lace, neck, hand and penis.
Like Dr Tan's patient he was reluctant to admit cause and effect. He said that he took one or two tablets of the drug only very occasionally, when his diverticulitis was troublesome. He had taken cotrimoxazole during several periods of two or three weeks without ill effect.
Patch tests were not applied but, because of his story of trouble after visiting the dentist, intradermal injections of 0.05 ml 1 % procaine and I % lignocaine were given in affected and unaffected sites. They provoked no immediate or delayed reactions. Papular Mucinosis (Scieromyxedema of Arndt-Gottron) Associated with Paraprotein IgG Kappa Type W D Brigden MRcp (for H T Calvert FRCP) (Royal Berkshire Hospital, Reading) RB, man aged 58 History: May 1972: attack of headache and slurring of speech; became confused, corner of mouth drooped, and weakness developed in right arm and leg. In total, six such attacks with complete recovery, except for mild loss of memory. Angiogram showed slight irregularity at base of left internal carotid artery, which was interpreted as an atheromatous plaque (Fig 1) . Warfarin was begun in October 1972, since when there have been no such attacks. Skin change first noticed in November 1972, which was brought to our notice in February 1973. A few papules on trunk and a suggestion of some infiltration over bridge of nose. Where the papules were most closely grouped there was also a diffuse thickening of the skin which had produced abnormally large skin folds (Fig 2) . Histology (Fig 3) Separation of collagen fibres in upper dermis due to accumulation of mucin. Leg skin biopsy showing mucin arranged diffusely in bandflike fashion in upper third of dermis.
Accumulation more localized and consistent with papular clinical changes on back skin biopsy. Increase in number of fibrocytes and some pigmentary incontinence. 
